newsfilter
← Latest News
Business Wire·

Astria Therapeutics to Present at Upcoming 2025 US Hereditary Angioedema Association National Summit

Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present four posters at the 2025 US